phosphoserine has been researched along with cyc 202 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ball, HM; Blaydes, JP; Hupp, TR; Luciani, MG; Pospisilova, S; Vojtesek, B | 1 |
Gueorguieva, M; Horky, M; Wesierska-Gadek, J | 1 |
Balk, SP; Bubley, GJ; Chen, S; Xu, Y; Yuan, X | 1 |
3 other study(ies) available for phosphoserine and cyc 202
Article | Year |
---|---|
Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription.
Topics: Antibodies, Monoclonal; DNA; Enzyme Inhibitors; Humans; Phosphorylation; Phosphoserine; Point Mutation; Purines; Roscovitine; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays | 2001 |
Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Caspase 3; Caspases; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Membrane Potentials; Mitochondria; Phosphorylation; Phosphoserine; Proteins; Purines; Roscovitine | 2005 |
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
Topics: Androgens; CDC2 Protein Kinase; Cell Line, Tumor; Humans; Male; Phosphorylation; Phosphoserine; Prostatic Neoplasms; Protein Kinase Inhibitors; Purines; Receptors, Androgen; Roscovitine; Transcription, Genetic | 2006 |